Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:2544-2552
Published online before print November 12, 2007, doi: 10.1161/CIRCULATIONAHA.107.698977
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: November 27, 2007, Volume 116, Number 22
Right arrow Data Supplement
Right arrow All Versions of this Article:
116/22/2544    most recent
CIRCULATIONAHA.107.698977v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, G. J.
Right arrow Articles by Angelini, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, G. J.
Right arrow Articles by Angelini, G. D.
Related Collections
Right arrow Other Treatment
Right arrow CV surgery: aortic and vascular disease
Right arrow CV surgery: coronary artery disease
Right arrow CV surgery: valvular disease
Right arrow CV surgery: other
Right arrowRelated Article

(Circulation. 2007;116:2544-2552.)
© 2007 American Heart Association, Inc.


Cardiovascular Surgery

Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery

Gavin J. Murphy, BSc, ChB, MD, FRCS(CTh); Barnaby C. Reeves, BA, MSc, DPhil; Chris A. Rogers, BSc, PhD; Syed I.A. Rizvi, MBBCh, MRCS; Lucy Culliford, BSc, MSc, PhD; Gianni D. Angelini, MCh, MD, FRCS, FETCS

From the Bristol Heart Institute, University of Bristol, Bristol, United Kingdom.

Correspondence to Dr B.C. Reeves, Bristol Heart Institute, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK. E-mail barney.reeves{at}bristol.ac.uk

Received February 26, 2007; accepted August 31, 2007.

Background— Red blood cell transfusion can both benefit and harm. To inform decisions about transfusion, we aimed to quantify associations of transfusion with clinical outcomes and cost in patients having cardiac surgery.

Methods and Results— Clinical, hematology, and blood transfusion databases were linked with the UK population register. Additional hematocrit information was obtained from intensive care unit charts. Composite infection (respiratory or wound infection or septicemia) and ischemic outcomes (myocardial infarction, stroke, renal impairment, or failure) were prespecified as coprimary end points. Secondary outcomes were resource use, cost, and survival. Associations were estimated by regression modeling with adjustment for potential confounding. All adult patients having cardiac surgery between April 1, 1996, and December 31, 2003, with key exposure and outcome data were included (98%). Adjusted odds ratios for composite infection (737 of 8516) and ischemic outcomes (832 of 8518) for transfused versus nontransfused patients were 3.38 (95% confidence interval [CI], 2.60 to 4.40) and 3.35 (95% CI, 2.68 to 4.35), respectively. Transfusion was associated with increased relative cost of admission (any transfusion, 1.42 times [95% CI, 1.37 to 1.46], varying from 1.11 for 1 U to 3.35 for >9 U). At any time after their operations, transfused patients were less likely to have been discharged from hospital (hazard ratio [HR], 0.63; 95% CI, 0.60 to 0.67) and were more likely to have died (0 to 30 days: HR, 6.69; 95% CI, 3.66 to 15.1; 31 days to 1 year: HR, 2.59; 95% CI, 1.68 to 4.17; >1 year: HR, 1.32; 95% CI, 1.08 to 1.64).

Conclusions— Red blood cell transfusion in patients having cardiac surgery is strongly associated with both infection and ischemic postoperative morbidity, hospital stay, increased early and late mortality, and hospital costs.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2007 116: 2513. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. R. Herman, K. J. Buth, B. A. Kent, and G. M. Hirsch
Clopidogrel Increases Blood Transfusion and Hemorrhagic Complications in Patients Undergoing Cardiac Surgery.
Ann. Thorac. Surg., February 1, 2010; 89(2): 397 - 402.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. M. Murkin, F. Falter, J. Granton, B. Young, C. Burt, and M. Chu
High-Dose Tranexamic Acid Is Associated with Nonischemic Clinical Seizures in Cardiac Surgical Patients
Anesth. Analg., February 1, 2010; 110(2): 350 - 353.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. H. Levy, R. P. Dutton, J. C. Hemphill III, A. Shander, D. Cooper, M. J. Paidas, C. M. Kessler, J. B. Holcomb, J. H. Lawson, and for the Hemostasis Summit Participants
Multidisciplinary Approach to the Challenge of Hemostasis
Anesth. Analg., February 1, 2010; 110(2): 354 - 364.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. C. Matthews, F. D. Pagani, J. W. Haft, T. M. Koelling, D. C. Naftel, and K. D. Aaronson
Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality
Circulation, January 19, 2010; 121(2): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
A. H.M. van Straten, M. W.A. Bekker, M. A. Soliman Hamad, A. A.J. van Zundert, E. J. Martens, J. P.A.M. Schonberger, and A. M. de Wolf
Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up
Interactive CardioVascular and Thoracic Surgery, January 1, 2010; 10(1): 37 - 42.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
S. Senay, F. Toraman, H. Karabulut, and C. Alhan
Is it the patient or the physician who cannot tolerate anemia? A prospective analysis in 1854 non-transfused coronary artery surgery patients
Perfusion, November 1, 2009; 24(6): 373 - 380.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
J. F. Baker and A. J. Ghio
Iron homoeostasis in rheumatic disease
Rheumatology, November 1, 2009; 48(11): 1339 - 1344.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. De Santo, G. Romano, A. Della Corte, V. de Simone, F. Grimaldi, M. Cotrufo, and M. de Feo
Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury
J. Thorac. Cardiovasc. Surg., October 1, 2009; 138(4): 965 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. C. Christensen, S. Krapf, A. Kempel, and C. von Heymann
Costs of excessive postoperative hemorrhage in cardiac surgery
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 687 - 693.
[Abstract] [Full Text] [PDF]


Home page
American Journal of Medical QualityHome page
F. W. Maddux, T. A. Dickinson, D. Rilla, R. W. Kamienski, S. P. Saha, F. Eales, A. Rego, H. W. Donias, S. L. Crutchfield, and R. A. Hardin
Institutional Variability of Intraoperative Red Blood Cell Utilization in Coronary Artery Bypass Graft Surgery
American Journal of Medical Quality, September 1, 2009; 24(5): 403 - 411.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Schimmer and R. Leyh
Reply.
Ann. Thorac. Surg., August 1, 2009; 88(2): 708 - 708.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. Wang, D. Bainbridge, J. Martin, and D. Cheng
The Efficacy of an Intraoperative Cell Saver During Cardiac Surgery: A Meta-Analysis of Randomized Trials
Anesth. Analg., August 1, 2009; 109(2): 320 - 330.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. A. J. M. Huybregts, R. de Vroege, E. K. Jansen, A. W. van Schijndel, H. M. T. Christiaans, and W. van Oeveren
The Association of Hemodilution and Transfusion of Red Blood Cells with Biochemical Markers of Splanchnic and Renal Injury During Cardiopulmonary Bypass
Anesth. Analg., August 1, 2009; 109(2): 331 - 339.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Gill, M. Herbertson, A. Vuylsteke, P. S. Olsen, C. von Heymann, M. Mythen, F. Sellke, F. Booth, and T. A. Schmidt
Safety and Efficacy of Recombinant Activated Factor VII: A Randomized Placebo-Controlled Trial in the Setting of Bleeding After Cardiac Surgery
Circulation, July 7, 2009; 120(1): 21 - 27.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. Engoren, R. H. Habib, J. Hadaway, A. Zacharias, T. A. Schwann, C. J. Riordan, S. J. Durham, and A. Shah
The Effect on Long-Term Survival of Erythrocyte Transfusion Given for Cardiac Valve Operations
Ann. Thorac. Surg., July 1, 2009; 88(1): 95 - 100.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Landesberg, W. S. Beattie, M. Mosseri, A. S. Jaffe, and J. S. Alpert
Perioperative Myocardial Infarction
Circulation, June 9, 2009; 119(22): 2936 - 2944.
[Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
K. A. Samolyk
State-of-the-Art Blood Management in Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2009; 13(2): 118 - 121.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Modi, E. Rodriguez, W. C. Hargrove III, A. Hassan, W. Y. Szeto, and W. R. Chitwood Jr.
Minimally invasive video-assisted mitral valve surgery: A 12-year, 2-center experience in 1178 patients.
J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1481 - 1487.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
E. Blasco-Colmenares, T. M. Perl, E. Guallar, W. A. Baumgartner, J. V. Conte, D. Alejo, R. Pastor-Barriuso, A. R. Sharrett, and N. Faraday
Aspirin Plus Clopidogrel and Risk of Infection After Coronary Artery Bypass Surgery
Arch Intern Med, April 27, 2009; 169(8): 788 - 795.
[Abstract] [Full Text] [PDF]


Home page
pdiHome page
K. M. Chow, C. C. Szeto, B. C.-H. Kwan, K. Y. Chung, C. B. Leung, and P. K.-T. Li
FACTORS ASSOCIATED WITH SUDDEN DEATH IN PERITONEAL DIALYSIS PATIENTS
Perit. Dial. Int., January 1, 2009; 29(1): 58 - 63.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
L. A. Bockeria and R. G. Grigoryants
eComment: Re: The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study
Interactive CardioVascular and Thoracic Surgery, January 1, 2009; 8(1): 99 - 99.
[Full Text] [PDF]


Home page
ICVTSHome page
S. Senay, F. Toraman, S. Gunaydin, M. Kilercik, H. Karabulut, and C. Alhan
The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study
Interactive CardioVascular and Thoracic Surgery, January 1, 2009; 8(1): 93 - 99.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Modi, A. Hassan, and W. R. Chitwood Jr.
Minimally invasive mitral valve surgery: a systematic review and meta-analysis
Eur. J. Cardiothorac. Surg., November 1, 2008; 34(5): 943 - 952.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. G.T. Augoustides
Letter by Augoustides Regarding Article, "Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery"
Circulation, June 24, 2008; 117(25): e506 - e506.
[Full Text] [PDF]


Home page
CirculationHome page
B. C. Reeves, G. J. Murphy, C. A. Rogers, L. Culliford, S. I.A. Rizvi, and G. D. Angelini
Response to Letter Regarding Article, "Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery"
Circulation, June 24, 2008; 117(25): e507 - e507.
[Full Text] [PDF]


Home page
HeartHome page
J.-P. Bassand
Bleeding and transfusion in acute coronary syndromes: a shift in the paradigm
Heart, May 1, 2008; 94(5): 661 - 666.
[Full Text] [PDF]


Home page
CirculationHome page
J. D. Rawn
Blood Transfusion in Cardiac Surgery: A Silent Epidemic Revisited
Circulation, November 27, 2007; 116(22): 2523 - 2524.
[Full Text] [PDF]